Cigna Shares Hit 52-Week Low on Trump Bid to Kill ACA By Investing.com


© Reuters.

Investing.com – The Trump Administration wants the entire Affordable Care Act (also known as Obamacare) declared unconstitutional and Cigna (NYSE:) shares fell back Tuesday as a result.

The shares were down 1.8% Tuesday afternoon and hit a 52-week low of $160.37. The shares are off 29% since peaking on Dec. 3 and down more than 15% this year.

The administration’s position came in a letter sent to the Fifth Circuit Court of Appeals. The court is hearing an appeal of a Texas court decision that declared the entire ACA unconstitutional.

The administration told the appeals court that “it is not urging that any portion of the district court’s judgment be reversed,” the New York Times reported.

Health-insurance stocks generally were lower on Tuesday.

UnitedHealth Group (NYSE:), off 1.6%, was the worst performer among the 30 stocks in the , and Molina Healthcare (NYSE:) was off 9.5%.

Critics of the Administration’s current position, who include the health-insurance industry, say gutting the ACA entirely will take away insurance coverage from as many as 100 million Americans and cause chaos for consumers, healthcare providers and health-insurance companies.

The case will likely be appealed to the Supreme Court no matter who wins on the appeal. It will also likely be a political issue for the 2020 election.

Cigna $2.46 a share in the fourth quarter on revenue of $14.3 billion. Both beat estimates from analysts polled by Investing.com. The stock has been weak since December in part because of the uncertainty created by the Texas ACA decision.

Cigna will be spending much of this year digesting its $67-billion acquisition pharmacy benefit manager Express Scripts (NASDAQ:).

Its 2019 results won’t be comparable to 2018 because the Express Scripts deal. The current Investing.com consensus is earnings of $3.76 a share on revenue of $34.1 billion.

The Express Scripts deal is part of an industry trend for health insurers and pharmacy management operations to combine in hopes of cutting prices. But the deals also will intensify competition. United Health owns Optum Rx and drugstore chain CVS Health (NYSE:)) bought Aetna (NYSE:) in a $70 billion deal in late 2018.

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.





Source link

Leave a Reply

Your email address will not be published. Required fields are marked *